You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Receptor Pathway Inhibitor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Metastatic Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Prostate Carcinoma Metastatic to the Bone Trial in Duarte,

Completed
  • Metastatic Prostate Carcinoma
  • +2 more
  • Robotic Assisted Radical Prostatectomy
  • +4 more
  • Duarte, California
  • +2 more
Apr 7, 2021

Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

Recruiting
  • Triple-negative Breast Cancer
  • Pyrotinib with Capecitabine
  • +6 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 8, 2022

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Breast Cancer Trial in East Melbourne (BYl719)

    Completed
    • Metastatic Breast Cancer
    • East Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Aug 11, 2022

    Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

    Active, not recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
    Jan 27, 2023

    Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

    Not yet recruiting
    • Castrate Resistant Prostate Cancer
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Mar 1, 2023

    Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Manchester, Greater Manchester, United Kingdom
    • +6 more
    Jan 5, 2023

    Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,

    Active, not recruiting
    • Chronic Kidney Disease (CKD)
    • +2 more
    • Jacksonville, Florida
      University of Florida Jacksonville
    Aug 5, 2022

    Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

    Recruiting
    • Breast Neoplasm Female
    • +3 more
    • New York, New York
    • +1 more
    Dec 21, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +5 more
    • PI3K inhibitor BYL719
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 14, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

    Completed
    • Metastatic Castration-resistant Prostate Cancer
    • NKTR-214 (Cohort A)
    • +6 more
    • Los Angeles, California
    • +5 more
    Nov 10, 2022

    Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial

    Not yet recruiting
    • Adenocarcinoma Esophagus
    • +3 more
    • (no location specified)
    Sep 13, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Feb 28, 2023

    Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

    Not yet recruiting
    • Breast Cancer
    • Marseille, France
      Institut Paoli Calmettes
    Aug 9, 2023

    COVID-19 Trial (Drug: Isotretinoin plus Tamoxifen, Aerosolized Isotretinoin plus Tamoxifen)

    Not yet recruiting
    • COVID-19
    • Drug: Isotretinoin plus Tamoxifen
    • Aerosolized Isotretinoin plus Tamoxifen
    • (no location specified)
    Jul 10, 2021

    COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis

    Not yet recruiting
    • COVID19
    • Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
    • +4 more
    • Cairo, Kafr El-sheikh, Egypt
    • +1 more
    Jul 29, 2021

    Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

    Not yet recruiting
    • Lung Cancer
    • Non Small Cell Lung Cancer
    • Amivantamab 1050mg
    • +2 more
    • Aurora, Colorado
    • +2 more
    Apr 25, 2023

    Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

    Recruiting
    • Salivary Gland Cancer
    • Nagoya, Aichi, Japan
    • +11 more
    Jan 21, 2023

    Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

    Available
    • Castration-Resistant Prostatic Cancer
    • (no location specified)
    Sep 11, 2023

    Advanced Breast Cancer Trial in Spain (CB-103)

    Active, not recruiting
    • Advanced Breast Cancer
    • Alzira, Spain
    • +14 more
    Jun 7, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Phase I and Phase II: LAE001/prednisone + afuresertib
    • Tucson, Arizona
    • +16 more
    Nov 30, 2022

    Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

    Recruiting
    • Metastatic Breast Cancer
    • Enobosarm & Abemaciclib Combo
    • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
    • Chandler, Arizona
    • +29 more
    Feb 1, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022